JP7061560B2 - スフィンゴミエリン吸収促進用兼紅斑生成抑制用発酵乳ならびにその使用方法およびその製造方法、スフィンゴミエリンの吸収を促進させると共に紅斑の生成を抑制する方法、乳酸菌産生物およびスフィンゴミエリンを含有する発酵乳 - Google Patents

スフィンゴミエリン吸収促進用兼紅斑生成抑制用発酵乳ならびにその使用方法およびその製造方法、スフィンゴミエリンの吸収を促進させると共に紅斑の生成を抑制する方法、乳酸菌産生物およびスフィンゴミエリンを含有する発酵乳 Download PDF

Info

Publication number
JP7061560B2
JP7061560B2 JP2018507405A JP2018507405A JP7061560B2 JP 7061560 B2 JP7061560 B2 JP 7061560B2 JP 2018507405 A JP2018507405 A JP 2018507405A JP 2018507405 A JP2018507405 A JP 2018507405A JP 7061560 B2 JP7061560 B2 JP 7061560B2
Authority
JP
Japan
Prior art keywords
sphingomyelin
erythema
formation
fermented milk
suppressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018507405A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2017164298A1 (ja
Inventor
雅史 森藤
恭子 伊藤
晶美 北出
朝幸 深澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Co Ltd
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of JPWO2017164298A1 publication Critical patent/JPWO2017164298A1/ja
Application granted granted Critical
Publication of JP7061560B2 publication Critical patent/JP7061560B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2018507405A 2016-03-24 2017-03-23 スフィンゴミエリン吸収促進用兼紅斑生成抑制用発酵乳ならびにその使用方法およびその製造方法、スフィンゴミエリンの吸収を促進させると共に紅斑の生成を抑制する方法、乳酸菌産生物およびスフィンゴミエリンを含有する発酵乳 Active JP7061560B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016060235 2016-03-24
JP2016060235 2016-03-24
PCT/JP2017/011682 WO2017164298A1 (fr) 2016-03-24 2017-03-23 Composition d'inhibition d'érythème, son procédé d'utilisation, son procédé de préparation, procédé d'inhibition d'érythème, et produit de bactéries d'acide lactique

Publications (2)

Publication Number Publication Date
JPWO2017164298A1 JPWO2017164298A1 (ja) 2019-01-31
JP7061560B2 true JP7061560B2 (ja) 2022-04-28

Family

ID=59900331

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018507405A Active JP7061560B2 (ja) 2016-03-24 2017-03-23 スフィンゴミエリン吸収促進用兼紅斑生成抑制用発酵乳ならびにその使用方法およびその製造方法、スフィンゴミエリンの吸収を促進させると共に紅斑の生成を抑制する方法、乳酸菌産生物およびスフィンゴミエリンを含有する発酵乳

Country Status (4)

Country Link
JP (1) JP7061560B2 (fr)
CN (1) CN109475583B (fr)
SG (2) SG10201912918TA (fr)
WO (1) WO2017164298A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7267020B2 (ja) * 2019-01-24 2023-05-01 株式会社明治 血糖値上昇抑制作用を有する発酵乳

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015137423A1 (fr) 2014-03-14 2015-09-17 株式会社 明治 Inducteur pour lait fermenté, produit alimentaire de type crème glacée peu gras ou dépourvu de graisse et procédé de production de produit alimentaire de type crème glacée peu gras ou dépourvu de graisse
WO2016021573A1 (fr) 2014-08-04 2016-02-11 株式会社明治 Agent permettant de favoriser la production de céramide lié de manière covalente à une cellule cornée

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0517363A (ja) * 1991-07-11 1993-01-26 Yakult Honsha Co Ltd 抗炎症剤及びそれを含有する化粧料
AU2003210311C1 (en) * 2002-02-21 2009-04-02 Societe Des Produits Nestle S.A. Pet food composition for skin photoprotection
WO2006095764A1 (fr) * 2005-03-09 2006-09-14 Calpis Co., Ltd. Agent pour supprimer la sensibilite de la peau aux rayons uv et aliment et boisson fonctionnels
JP2008179601A (ja) * 2006-12-28 2008-08-07 Suntory Ltd ラクトバチルス属菌を含む美容組成物
KR101757504B1 (ko) * 2010-06-28 2017-07-12 가부시키가이샤 야쿠르트 혼샤 경구용 피부 성상 개선제
KR101226758B1 (ko) * 2010-09-28 2013-01-25 한국 한의학 연구원 생약 추출물 또는 이의 유산균 발효물을 포함하는 아토피 피부염의 예방 또는 치료용 조성물
TW201630596A (zh) * 2015-01-06 2016-09-01 Meiji Co Ltd 鞘脂質吸收促進劑

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015137423A1 (fr) 2014-03-14 2015-09-17 株式会社 明治 Inducteur pour lait fermenté, produit alimentaire de type crème glacée peu gras ou dépourvu de graisse et procédé de production de produit alimentaire de type crème glacée peu gras ou dépourvu de graisse
WO2016021573A1 (fr) 2014-08-04 2016-02-11 株式会社明治 Agent permettant de favoriser la production de céramide lié de manière covalente à une cellule cornée

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Microb. Ecol. Health Dis., (2002), 14, [1], p.4-13
腸内細菌学雑誌, (2008), 22, [1], p.1-5

Also Published As

Publication number Publication date
SG11201806603YA (en) 2018-09-27
SG10201912918TA (en) 2020-02-27
WO2017164298A1 (fr) 2017-09-28
CN109475583A (zh) 2019-03-15
CN109475583B (zh) 2022-07-29
JPWO2017164298A1 (ja) 2019-01-31

Similar Documents

Publication Publication Date Title
JP5923238B2 (ja) 迷走神経活性化剤
ES2272493T3 (es) Producto alimenticio que contiene lactobacilos no viables.
JP7121657B2 (ja) 除脂肪体重を増加させるためのビフィズス菌(Bifidobacterium)
JP6551934B2 (ja) ビフィドバクテリウム属細菌および/または乳酸菌の増殖促進および/または減少抑制剤
JP6773562B2 (ja) スフィンゴ脂質吸収促進剤
Carminati et al. Nutritional value and potential health benefits of donkey milk
JP7061560B2 (ja) スフィンゴミエリン吸収促進用兼紅斑生成抑制用発酵乳ならびにその使用方法およびその製造方法、スフィンゴミエリンの吸収を促進させると共に紅斑の生成を抑制する方法、乳酸菌産生物およびスフィンゴミエリンを含有する発酵乳
JP6037595B2 (ja) 満腹感誘導組成物及びその製造方法
JP5950993B2 (ja) 迷走神経活性化剤
KR102538090B1 (ko) 단백질 분해능을 가지는 락토바실러스 카제이 idcc 3451을 포함하는 식품 조성물 및 건강기능식품
KR102523775B1 (ko) 단백질 분해능을 가지는 락토바실러스 플란타럼 idcc 3501을 포함하는 식품 조성물 및 건강기능식품
JP4716769B2 (ja) 血圧降下剤の製造方法
KR102423025B1 (ko) 단백질 분해능을 가지는 락토바실러스 람노서스 idcc 3201을 포함하는 식품 조성물 및 건강기능식품
WO2019188943A1 (fr) Composition pour prévenir et/ou améliorer une diminution du débit sanguin cérébral
KR102073175B1 (ko) 고지혈증 예방 또는 개선용 건강기능식품
JPWO2006093013A1 (ja) 血清コレステロール低下材およびその製造方法、ならびに血清コレステロール低下作用を有する食品組成物および医薬組成物
JP6849890B2 (ja) デオキシリボ核酸保存用組成物およびその製造方法、デオキシリボ核酸を保存する方法、乳酸菌産生物およびその使用方法
WO2016021573A1 (fr) Agent permettant de favoriser la production de céramide lié de manière covalente à une cellule cornée
RU2583311C2 (ru) Получение йогурта функционального назначения с натуральными добавками
US20100129495A1 (en) Serum cholestrol-lowering material, process for producing same
Dey et al. Studies on sensory attributes of cereal based fermented functional milk
Rață Research on the goat milk yogurt with fruits obtaining and quality index characteristics of it
JP2022144264A (ja) 乳酸菌又はその培養物を含む豆乳発酵物
WO2016104665A1 (fr) Agent pour inhiber ou améliorer la diminution de loricrine, activateur de transglutaminase-3, et agent pour favoriser la formation d'enveloppe cornée de couche de cellule morte de peau ou pour renforcer la structure d'enveloppe cornée de couche de cellule morte de peau
TW201825011A (zh) 蛋白質效率提升用之組成物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210513

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211012

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211201

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220412

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220418

R150 Certificate of patent or registration of utility model

Ref document number: 7061560

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150